AI
Thursday, April 24, 2008 4:05:31 PM
>>the FDA presumably had an opportunity to see a practical application of MNTA’s characterization technology.
Why didn't they use Amphastar's technology?
or Teva's?
zip
Why didn't they use Amphastar's technology?
or Teva's?
zip
There are times when rules and precedents cannot be broken; others when they cannot be adhered to with safety. (Thomas Joplin)
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
